微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2025-06-30 | 1.23% | 6.96% | 289.23% | 92/158 | 0.26% | 翰宇药业 | 18.95% | 行业排名> |
| 2025-03-31 | -0.65% | -153.72% | -127.2% | 119/158 | -0.37% | 翰宇药业 | 11.39% | 行业排名> |
| 2024-12-31 | 2.39% | 35.03% | -59.63% | 83/158 | -9.52% | 百利天恒 | 181.27% | 行业排名> |
| 2024-09-30 | 5.92% | 150.85% | 414.78% | 61/158 | 4.23% | 百利天恒 | 186.1% | 行业排名> |
| 2024-06-30 | 1.15% | 43.75% | -4.96% | 99/158 | 2.66% | 百利天恒 | 186.89% | 行业排名> |
| 2024-03-31 | 1.21% | 18.63% | -31.64% | 84/158 | 2.32% | 百利天恒 | 188.56% | 行业排名> |
| 2023-12-31 | 1.77% | -67.52% | -25% | 91/158 | -1.03% | 小方制药 | 41.8% | 行业排名> |
| 2023-09-30 | 2.36% | -63.13% | 195% | 100/158 | 2.34% | 拓新药业 | 20.51% | 行业排名> |
| 2023-06-30 | 0.8% | -80.1% | -21.57% | 105/158 | 1.46% | 拓新药业 | 19.87% | 行业排名> |
| 2023-03-31 | 1.02% | -69% | -81.28% | 92/158 | 1.37% | 拓新药业 | 19.91% | 行业排名> |
| 2022-12-31 | 5.45% | -81.81% | -14.84% | 70/158 | 0.67% | 小方制药 | 55.57% | 行业排名> |
| 2022-09-30 | 6.4% | -83.69% | 59.2% | 55/158 | 2.8% | 福元医药 | 25.41% | 行业排名> |
| 2022-06-30 | 4.02% | -85.71% | 22.19% | 58/158 | 2.16% | 小方制药 | 34.81% | 行业排名> |
| 2022-03-31 | 3.29% | -79.23% | -89.02% | 31/158 | 1.57% | 退市金泰 | 10.74% | 行业排名> |
| 2021-12-31 | 29.96% | -46.44% | -23.67% | 4/158 | 0.75% | 人福医药 | 6.82% | 行业排名> |
| 2021-09-30 | 39.25% | 2% | 39.48% | 1/158 | 4.43% | 小方制药 | 71.99% | 行业排名> |
| 2021-06-30 | 28.14% | -11.79% | 77.65% | 1/158 | 2.94% | 汇宇制药 | 39.25% | 行业排名> |
| 2021-03-31 | 15.84% | 2% | -71.68% | 2/158 | 2.49% | 汇宇制药 | 28.14% | 行业排名> |
| 2020-12-31 | 55.94% | 2% | 75.36% | 1/158 | 3.58% | 哈三联 | 27.17% | 行业排名> |
| 2020-06-30 | 31.9% | 2% | 2% | 1/158 | 4.19% | 汇宇制药 | 55.94% | 行业排名> |